President and CEO
In addition to his post at Canon U.S. Life Sciences, Inc.(CLS) Toru Nishizawa is the Executive Vice President of Canon Virginia Inc. Prior to joining CLS he was the Group Executive of Office Imaging Products Business Support Group, where he led service strategies for office imaging products and was integral to the Oce` integration. Mr. Nishizawa joined Canon in 1980 in the Office Imaging Products Group and was quickly assigned to Canon Giessen GmbH. He spent nearly 10 years in Germany then returned to Japan for the product planning and launch of the Digital Color Copier. In 2004, Nishizawa accepted the role of president of Canon Giessen GmbH and returned to Germany. Nishizawa graduated from Tokyo Institute of Technology with a major in management engineering in 1980.
Click here for President's Message.
Ivor Knight, Ph.D.
Senior Vice President and Chief Technical Officer
Dr. Ivor Knight established the Research & Development division of Canon U.S. Life Sciences, Inc. He has over two decades experience in molecular genetic research and the development of DNA-based diagnostic systems. He received a B.S. in Animal and Veterinary Science from West Virginia University, and a Ph.D. in Microbiology from the University of Maryland at College Park.
Senior Fellow, Canon USA; Professor of the Practice, BioEngineering, University of Maryland
Hiroshi Inoue brings 28 years of experience in instrument development to his position at Canon U.S. Life Sciences, Inc.(CLS) — 21 of which were spent at Canon. Under his leadership, the Canon NAT group was the co-recipient of a grant from the Japanese government's NEDO (New Energy and Industrial Technology Development Organization), to create a working DNA-based system for cancer analysis in clinical settings. Inoue is an alumnus of the Engineering Science School at Osaka University (1977), and is the registrant of over 300 US/PTC/Japanese patents. Hiroshi Inoue was appointed as Professor of the Practice of the Fischell Department of Bioengineering from the University of Maryland in 2011. At the University of Maryland, he is researching novel molecular diagnosis systems.
Vice President, Business Development and Administration
With 28 years at Canon, Shinji Mori joined Canon U.S. Life Sciences, Inc.(CLS) in 2005. Mr. Mori spent nearly 20 years at Canon exploring new business development opportunities in a variety of roles and nearly 10 years working in Canon Corporate Communications for Canon U.S.A., Inc. For a decade, Mori performed business planning activities for Canon's life sciences efforts, including a post managing the DNA microarray division of Canon Inc., prior to joining Canon U.S. Life Sciences, Inc.
Renée Michelle Howell, Ph.D.
Director, Life Sciences R&D
Dr. Howell currently leads R&D efforts at Canon U.S. Life Sciences, Inc. She is a molecular biologist with 17 years of experience in IVD and life sciences Product Development and Operations. Prior to joining Canon, she worked for a global in vitro diagnostic company where her primary responsibilities were development of HPV genotyping assays and reagents for a next generation HPV screening assay. Dr. Howell received a BS in Medical Technology from Rutgers University. She earned her Ph.D. degree from Rutgers University and the University of Medicine and Dentistry of New Jersey where her dissertation research focused on genetic variation in HIV-1. She is active in the Tech Council of Maryland, a member of ASM, AMP, and volunteers with the Clinical Laboratory Standards Institute.